Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery
Information source: New York University School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Neuromuscular Blockade
Intervention: Rocuronium Bromide, Cisatracurium Besylate (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: New York University School of Medicine Official(s) and/or principal investigator(s): Aleksandar Beric, MD, Principal Investigator, Affiliation: Neurologist
Overall contact: Brane Gavrancic, MD, Phone: 2015648602, Email: brane.gavrancic@nyumc.org
Summary
During lumbar spine fusion surgery intraoperative neurophysiological monitoring is in
routine use for prevention of possible nerve injuries during placement of screw into
pedicle. Pedicle screw stimulation test is performed to assess if screw placement is
encroaching on the nerve roots. Relative distance between the pedicle screw and the
neighbouring root can be estimated by the intensity of the current required to activate the
root and appropriate muscle. A properly placed screw can be distinguished from those
perforating the pedicle wall by its higher minimum level of electrical current needed to
elicit a muscle response. The minimum level is deemed as threshold. This test is based on
compound muscle action potential (CMAP) and use of neuromuscular blocking agents (NMBA)
should be avoided because of possible cause of false negative results of screw stimulation
test. Neuromuscular blocking agents, which are in routine use during anesthesia, will have
effect on muscle action potential. When NMBA are used current stimulus will depolarize the
same number of axons and the associated muscle response will be present but of lower
amplitude because some percentage of motor fibers will be blocked by activity of NMBA. At
this point, stronger stimulus is needed to recruit additional axons/muscle fibers , and
hence, the measured threshold is elevated.
Train of four (TOF) test is method used to determine level of neuromuscular blockade, by
stimulation of peripheral nerve and following induced muscle contractions. Interpretation of
muscle contractions may be by subjective (visual) or objective (quantitative) method.
Quantitative TOF test may be used prior screw stimulation test by calculating T4/T1 ratio
and obtaining quantitative value which shows level of neuromuscular blockade. Residual
neuromuscular blockade may be present before screw stimulation test, and effect on accuracy
of this test in this situation was not clearly investigated in recent studies.
The purpose of this study would be to determine changes of screw stimulation thresholds
under different range of neuromuscular blockade. Therefore, acceptable neuromuscular blockade
threshold (determined by TOF test) acceptable for obtaining reliable screw stimulation test
should be determined. Screw stimulation test may be performed when neuromuscular blockade is
absent and compared to repeated screw stimulation test when neuromuscular blockade is
present. Different levels of neuromuscular blockade may provide different results on screw
stimulation test, so if difference is statistically significant, induced neuromuscular
blockade level may be set as threshold value, acceptable for obtaining reliable testing
results.
Clinical Details
Official title: Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Train of four (TOF) test
Eligibility
Minimum age: 18 Years.
Maximum age: 85 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Subjects undergoing lumbar spine fusion surgery with neurophysiologic intraoperative
monitoring when pedicle screw stimulation test is performed.
- Subjects of both gender
- Age 18-85
- With diagnosis of lumbar spinal stenosis.
- All subjects capable of giving informed consent in order to be included for the
study.
Exclusion Criteria:
- Subjects with medical history of presence of neuromuscular diseases
- Any renal and liver diseases.
Locations and Contacts
Brane Gavrancic, MD, Phone: 2015648602, Email: brane.gavrancic@nyumc.org
NYU Langone Medical Center, Hospital for Joint Diseases, New York, New York 10003, United States; Recruiting Brane Gavrancic, Email: Brane.gavrancic@nyumc.org Aleksandar Beric, MD, Principal Investigator Brane Gavrancic, MD, Sub-Investigator Athena Lolis, MD, Sub-Investigator George Spessot, MD, Sub-Investigator
Additional Information
Starting date: January 2015
Last updated: January 30, 2015
|